Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Converting weak binders into infinite binders.

Todd M Corneillie1, Paul A Whetstone, Kelvin C Lee

  • 1Department of Chemistry, University of California, Davis, California 95616, USA.

Bioconjugate Chemistry
|November 18, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antibody with Infinite Affinity for In Vivo Tracking of Genetically Engineered Lymphocytes.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2018
Same author

The pharmacokinetics of Zr-89 labeled liposomes over extended periods in a murine tumor model.

Nuclear medicine and biology·2014
Same author

Development of a Radiolabeled Irreversible Peptide Ligand for PET Imaging of Vascular Endothelial Growth Factor.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2014
Same author

LC/ESI-MS/MS method for quantification of 28 synthetic cannabinoids in neat oral fluid and its application to preliminary studies on their detection windows.

Analytical and bioanalytical chemistry·2013
Same author

Introduction to gene silencing and delivery.

Accounts of chemical research·2012
Same author

Enhancing peptide ligand binding to vascular endothelial growth factor by covalent bond formation.

Bioconjugate chemistry·2012
Same journal

Neutral Amphiphiles Boost Transfection Efficiency and Reduce Inflammation in Polymer Micelle-Mediated mRNA Delivery.

Bioconjugate chemistry·2026
Same journal

Surfactant-Mediated Buchwald-Hartwig Coupling of Aliphatic Amines for the Synthesis of DNA-Encoded Libraries.

Bioconjugate chemistry·2026
Same journal

Artificial Intelligence for Discovery in Life Sciences.

Bioconjugate chemistry·2026
Same journal

Iron Single Atom Nanozyme-Mediated GPX4 Inhibitor Delivery for Self-Enhanced Ferroptosis.

Bioconjugate chemistry·2026
Same journal

SpyCatcher-Engineered Ferritin Nanocages Enable Dual-Receptor Targeting for Enhanced Glioma Therapy.

Bioconjugate chemistry·2026
Same journal

One-Pot Synthesis of Functionalized Coumarin Fluorophores Enables Rapid Access to Live-Cell Bioorthogonal Labeling and Microenvironmental Sensing Agents.

Bioconjugate chemistry·2026
See all related articles

Engineered antibody 2D12.5 G54C captures rare earth metals and other elements. This antibody mutant enables permanent, selective attachment for diverse biological applications.

Area of Science:

  • Bioconjugation Chemistry
  • Protein Engineering
  • Radiopharmaceutical Development

Background:

  • Monoclonal antibody 2D12.5 effectively captures rare earth metals chelated with DOTA.
  • Engineering antibodies is crucial for enhancing their utility in biological applications.

Purpose of the Study:

  • To engineer the 2D12.5 antibody for broader metal-binding capabilities.
  • To create a permanent linkage system for metal complexes using antibody 2D12.5.

Main Methods:

  • Engineered a single cysteine residue into the heavy chain of 2D12.5 at position 54 (2D12.5 G54C mutant).
  • Utilized (S)-2-(4-acrylamidobenzyl)-DOTA (AABD) metal complexes for binding studies.
  • Assessed binding kinetics and permanent linkage formation at 37°C, pH 7.5.

Related Experiment Videos

Main Results:

  • The 2D12.5 G54C mutant demonstrated permanent binding of rare earth-AABD complexes within 5 minutes.
  • Indium-AABD and copper-AABD complexes also formed permanent linkages, despite lower affinities.
  • Binding yield correlated with affinity, but permanent attachment occurred even with significantly reduced affinity.

Conclusions:

  • The engineered 2D12.5 G54C antibody facilitates permanent attachment of a wide range of metal-AABD complexes, extending beyond rare earths.
  • This enhanced antibody offers a versatile platform for bioconjugation and radiolabeling applications.
  • The system exhibits selective and permanent attachment with structurally related ligands.